(Left to right): Lim Chuan Poh, Chairman, A*STAR; Low Teck Seng, MD,
A*STAR; Michael Idelchik, Vice President of Advanced Technology
Programs, GE Global Research; David Utama, President and CEO,
GE Healthcare ASEAN.
Medical Imaging Technologies
GE Global Research, the central technology development
arm for GE Healthcare and all of GE’s businesses, has signed
a Memorandum of Understanding (MOU) with Singapore’s
Agency of Science, Technology, and Research (A*STAR).
This collaboration will focus on advancing current medical
imaging technologies and diagnostics to enable more
accurate, earlier, and faster clinical diagnoses of cancer and
other diseases. As part of the MOU, GE Global Research and
A*STAR intend to collaborate to enhance medical imaging
technologies in imaging modalities such as MR.
Michael Idelchik, Vice President of Advanced Technology
Programs at GE Global Research, said, “To more effectively
combat cancer and other deadly diseases, more advanced
diagnostic tools will be needed to help doctors become
more prescriptive in their diagnoses and treatment regimens.
Combining A*STAR’s world-class biomedical and clinical
expertise with GE’s strengths in diagnostic and molecular
imaging, we have an exciting opportunity to take medical
diagnosis to this next level. Specifically, A*STAR will help us
address cancers and other diseases more common in Asia
and where pathology and outcomes are different as
compared to the rest of the world.”
For more information, visit
From left to right: Michela Tosetti, PhD (Department of Developmental
Neuroscience, Stella Maris Scientific Institute), Giovanni Cioni, MD
(Professor, Universita di Pisa), and Giovanni Cutajar (President, IMAG07).
First GE 7.0T MR in Europe
Europe’s first GE 7.0T MR imaging scanner‡‡—providing ultra-high
field, whole-body scanning capabilities for MR research—was
installed at the IRCCS Stella Maris Foundation in Pisa, Italy.
The scanner was acquired by a special research foundation,
IMAG07, consisting of the Stella Maris Foundation, the
University of Pisa, Cisanello University Hospital of Pisa,
IRCCS Eugenio Medea, and the University Hospital of Pisa.
The foundation’s primary interest includes neuroscience, and
all related disciplines, for the study of molecular phenomena in
vivo and in vitro. Additionally, its goals include coordination of
research (both basic and applied) in specialized areas of specific
interest of the member institutions; the promotion of scientific
collaboration between organizations, and with other agencies
and Founders Industries—both domestic and international; the
promotion of initiatives for popularizing science and training;
and to prepare expert researchers in the field.
To read about GE Healthcare and University of Iowa Health
Care collaborating on ultra-high field MR to study brain
disorders, please see pages 62–63.
‡‡ Investigational Device not commercially available. Limited by law to investigational
use in compliance with applicable local ethics and research requirements.